Recently, the Ran (Ras-related nuclear protein) and Brms1 (breast cancer metastasis suppressor 1) promoters were shown to display high activity—comparable to the CMV promoter—as well as cancer specificity in vivo in ovarian cancer (Bg-1 cells), prostate cancer (PC-3 cells) and breast cancer (MCF-7 cells) [21]. Here, BRMS1 is linked to prostate carcinoma.